SOFTFIL® PRECISION Micro-Cannula 22G/50mm

Manufacturing Information for Softfil Precision Micro-Cannula 22G/50mm

Softfil, a globally recognised brand, manufactures the Precision Micro-Cannula range in France. Other products in the Softfil Precision Micro-Cannula range include:

• Softfil Precision Micro-Cannula 25G/60mm: Designed for deeper injections in larger areas.
• Softfil Precision Micro-Cannula 22G/40mm: Offers precise delivery of thicker fillers.
• Softfil Precision Micro-Cannula 30G/25mm: Ideal for delicate areas with fine filler applications.
• Softfil Precision Micro-Cannula 25G/50mm: Versatile option for various facial areas.
• Softfil Precision Micro-Cannula 25G/40mm: Optimised for precise injections in sensitive areas.

Expected Benefits and Results of the Treatments

Using Softfil Precision Micro-Cannula 22G/50mm provides multiple benefits:

• Reduced bruising and swelling: Minimises trauma to blood vessels.
• Increased patient comfort: Blunt-tip design allows for smoother injections.
• Precise filler placement: Enhances aesthetic results with improved control.
• Lower risk of vascular complications: Safer alternative to sharp needles.
• Enhanced tissue integration: Provides natural-looking results.

Softfil Precision Micro-Cannula 22G/50mm Materials and Device Properties

The Softfil Precision Micro-Cannula is made from high-quality materials to ensure durability and safety:

• Stainless steel: Ensures flexibility, resistance, and precision in applications.
• Polyethylene: Provides a smooth, biocompatible surface to reduce friction.

Device properties:

• Blunt-tip design: Minimises tissue trauma and improves safety.
• Flexible micro-cannula: Enhances precision for optimal filler distribution.
• Pre-hole needle included: Allows for easy entry-point creation.

Included Items or Accessories

Each package contains:

• 20 pre-hole needles: Designed for precise entry-point creation.
• 20 sterile, single-use micro-cannulas: Ensures safety and hygiene in procedures.

Application Method for Softfil Precision Micro-Cannula 22G/50mm

To ensure optimal performance, follow these steps:

Pre-procedure:

• Inspect the packaging for sterility and integrity.
• Clean and disinfect the treatment area.

During procedure:

• Open the sterile packaging carefully.
• Attach the micro-cannula to a pre-filled syringe.
• Use the included pre-hole needle to create an entry point.
• Insert the micro-cannula through the entry site and administer filler gradually.

Post-procedure:

• Dispose of used items in a designated sharps container.
• Apply antiseptic if necessary and inform the patient about aftercare.

Guidelines for Proper Aftercare

Patients should follow these aftercare instructions:

• Avoid touching the treated area for at least 6 hours.
• Do not apply makeup for 24 hours to prevent infection.
• Avoid intense physical activity for 24-48 hours.
• Stay hydrated to promote better filler integration.
• Apply cold compresses if minor swelling occurs.
• Follow up with the practitioner if any unusual reactions occur.

Duration of Softfil Precision Micro-Cannula 22G/50mm 

Each micro-cannula is to be used only once and discarded afterwards according to protocols on eliminating medical waste.

Potential Risks and Side Effects

While Softfil Precision Micro-Cannula 22G/50mm is designed to minimise trauma and ensure safer injections, some side effects may still occur. These include:

• Bruising: Minor to moderate bruising at the injection site due to tissue manipulation.
• Swelling: Temporary swelling around the treated area, which usually subsides within a few days.
• Redness: Mild irritation or redness at the injection site.
• Pain or discomfort: Some patients may experience temporary sensitivity or tenderness in the treated area.
• Bleeding: Minor bleeding may occur when creating the entry point with the pre-hole needle.
• Infection: Though rare, improper injection technique or poor aftercare may lead to infection.
• Lumps or uneven texture: Filler may settle unevenly, requiring massage or correction.
• Delayed hypersensitivity reactions: Some patients may develop redness, swelling, or small nodules weeks or months after treatment.
• Vascular occlusion: If improperly administered, filler may enter a blood vessel, leading to complications like tissue necrosis.
• Nerve irritation or damage: Rare cases may involve temporary numbness or tingling due to nerve compression.
• Allergic reactions: Though uncommon, patients may have sensitivity to filler components or cannula materials.
• Skin discolouration: Temporary pigmentation changes, including blanching or darkening of the skin.
• Prolonged swelling or bruising: In some cases, side effects may last longer than expected due to individual healing responses.

Softfil Precision Micro-Cannula 22G/50mm Treatment Contraindications

This treatment is not suitable for certain individuals due to potential health risks. The following conditions and situations contraindicate the use of Softfil Precision Micro-Cannula 22G/50mm:

• Active skin infections or inflammation: Patients with bacterial, viral, or fungal infections in the treatment area should avoid injections.
• Bleeding disorders or blood-thinning medication use: Individuals with haemophilia, thrombocytopenia, or those taking anticoagulants (e.g., warfarin, aspirin) have a higher risk of excessive bleeding and bruising.
• Allergic reactions to filler components or cannula materials: Patients with known hypersensitivity to stainless steel, polyethylene, or filler ingredients should not undergo the procedure.
• Pregnant or breastfeeding individuals: There is insufficient research on the safety of dermal fillers during pregnancy and lactation.
• Autoimmune diseases or immunosuppressive conditions: Patients with lupus or rheumatoid arthritis or those undergoing immunosuppressive therapy may have an increased risk of complications.
• History of severe scarring or keloids: Individuals prone to excessive scar formation may experience poor healing or unsatisfactory cosmetic results.
• Uncontrolled diabetes: Poor circulation and delayed wound healing in diabetic patients may increase the risk of infection or complications.
• Recent dermal procedures or treatments: Patients who have recently undergone chemical peels, laser resurfacing, or other skin treatments should wait until the skin has fully healed.
• Neuromuscular disorders: Conditions such as myasthenia gravis or muscular dystrophy may interfere with the injection process or healing.
• Compromised immune system: Individuals undergoing chemotherapy or radiotherapy or with chronic infections should consult a specialist before considering treatment.
• Active cold sores (herpes simplex virus): Injection procedures can trigger flare-ups or spread the virus to other areas.
• Recent vaccinations: Patients who have received vaccines or immunotherapy within two weeks before the procedure should wait to reduce the risk of adverse reactions.
• Psychological disorders or body dysmorphia: Patients with unrealistic expectations or psychological conditions affecting self-image should undergo thorough consultation before treatment.
• Severe allergies or anaphylaxis history: Those with a history of severe allergic reactions should proceed with caution and may require a prior allergy test.
• Recent surgery in the treatment area: Patients who have undergone recent surgical procedures should wait until full recovery before aesthetic injections.